State Street Corp Has $75.77 Million Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

State Street Corp decreased its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 0.9% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 4,160,634 shares of the company’s stock after selling 39,008 shares during the period. State Street Corp’s holdings in Privia Health Group were worth $75,765,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of PRVA. Nisa Investment Advisors LLC increased its holdings in Privia Health Group by 107.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock valued at $31,000 after purchasing an additional 930 shares in the last quarter. Louisiana State Employees Retirement System raised its holdings in shares of Privia Health Group by 2.6% in the second quarter. Louisiana State Employees Retirement System now owns 52,200 shares of the company’s stock valued at $907,000 after buying an additional 1,300 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its position in Privia Health Group by 8.8% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 9,758 shares of the company’s stock worth $170,000 after buying an additional 788 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Privia Health Group by 7.5% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,742 shares of the company’s stock worth $413,000 after acquiring an additional 1,653 shares during the last quarter. Finally, Peregrine Capital Management LLC increased its position in Privia Health Group by 11.5% in the 2nd quarter. Peregrine Capital Management LLC now owns 314,190 shares of the company’s stock valued at $5,461,000 after acquiring an additional 32,311 shares in the last quarter. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Performance

Shares of NASDAQ:PRVA opened at $20.79 on Wednesday. The company has a 50 day moving average price of $20.12 and a two-hundred day moving average price of $19.10. The company has a market capitalization of $2.49 billion, a PE ratio of 207.92, a PEG ratio of 5.45 and a beta of 0.83. Privia Health Group, Inc. has a 52 week low of $15.92 and a 52 week high of $24.30.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on PRVA shares. KeyCorp began coverage on shares of Privia Health Group in a research report on Friday, October 11th. They set an “overweight” rating and a $23.00 target price on the stock. Robert W. Baird increased their price objective on Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, August 26th. Barclays boosted their target price on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. JPMorgan Chase & Co. raised their price target on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Friday, November 29th. Finally, Macquarie began coverage on Privia Health Group in a report on Monday. They set an “outperform” rating and a $25.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, Privia Health Group presently has a consensus rating of “Buy” and an average target price of $24.80.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.